← All organizations
Medical Center Leeuwarden
Academic/HospitalWebsite ↗
Also known as: Dept of intensive care, Medical Centre Leeuwarden, PO Box 888,8901BR Leeuwarden, The Netherlands | Medical Center Leeuwarden | Medical Centre Leeuwarden | Medical centrum Leeuwarden, Department of pulmonology | Medisch Centrum Leeuwarden
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2004Last known activity
Apr 1, 2023
Timeline
1980s
- Jan 1, 1982
Medical Center Leeuwarden— Founded
Drugs by trial phase (24 distinct, 17 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Angina, Unstable
- Carcinoma
- Carcinoma, Squamous Cell
- Critical Illness
- Diabetes, Gestational
- Infarction
- Insulin Resistance
- Myocardial Infarction
- Neutropenia
- Non-ST Elevated Myocardial Infarction
- Pheochromocytoma
- Renal Insufficiency
- Sepsis
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
- Ventricular Dysfunction
- Ventricular Dysfunction, Right
Recent trials (27)
- NCT06172010CollaboratorPhase 4Apr 1, 2023
- NCT04985435CollaboratorPhase 4May 12, 2021
- NCT04481256CollaboratorN/AOct 1, 2020
- NCT04061161Overall official - principal investigatorPhase 4Aug 20, 2019
- NCT03806582Lead sponsorPhase 4Mar 1, 2019
- NCT03806582Reponsible party - principal investigatorPhase 4Mar 1, 2019
- NCT03806582Overall official - principal investigatorPhase 4Mar 1, 2019
- NCT03646318CollaboratorPhase 4Sep 1, 2018
- NCT05693688CollaboratorPhase 4Dec 1, 2017
- NCT02738762Sponsor investigatorN/ANov 15, 2017
- NCT02738762Reponsible party - principal investigatorN/ANov 15, 2017
- NCT02738762Lead sponsorN/ANov 15, 2017
- NCT02947503CollaboratorPhase 3Jan 1, 2017
- NCT02054442CollaboratorPhase 1/Phase 2Aug 1, 2016
- NCT01974739Lead sponsorN/ASep 1, 2013
Details
- Founded
- Leeuwarden, NL Jan 1, 1982
- Last known activity
- Apr 1, 2023